Immix Biopharma Inc.

NASDAQ: IMMX · Real-Time Price · USD
2.27
0.08 (3.65%)
At close: Aug 15, 2025, 3:59 PM
2.27
0.00%
After-hours: Aug 15, 2025, 04:27 PM EDT

Immix Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-6.62M -4.54M -4.81M -7.15M -4.39M -5.33M -5.09M -4.34M -3.6M -2.5M -3.8M -1.54M -1.56M -1.33M -22.76M -403.26K -208.64K -1.02M
Depreciation & Amortization
79.83K 59.18K 41.34K 25.91K 24.3K 23.85K 3.08K 1.38K 506.00 505.00 566.00 566.00 383.00 620.00 620.00 620.00 620.00 608.00
Stock-Based Compensation
532.25K 868.36K 705.65K 733.81K 637.85K 943.26K 1.05M 737.33K 447.66K 329.92K 230.09K 163.19K 65.71K 65.07K 122.15K 61.86K 30.72K 4.25K
Other Working Capital
154.53K -332.45K 532.55K 284.31K 196.44K -476.1K 1.04M 446.83K -1.3M -190.81K -959.54K 189.34K 333.27K -389.39K -302.27K 2.44K 14.2K 652.00
Other Non-Cash Items
n/a n/a n/a n/a -12.91K n/a 602.8K 605.12K -535.76K 193.94K 295.16M 50K 616.35K -58.65K 16.62K 20.12K 19.73K 61.69K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -668.67K -605.12K 535.76K -193.94K -295.16M n/a n/a n/a 22.11M n/a -90K 825K
Change in Working Capital
700.7K 1.93M 2.59M 2.35M -1.51M 537.1K 1.42M 518.55K -365.3K 75.61K -334.75K -141.2K 899.62K -228.47K -609.16K 269.9K 89.56K -141.34K
Operating Cash Flow
-5.31M -1.69M -1.48M -4.04M -5.26M -3.83M -2.68M -3.09M -3.52M -2.09M -3.9M -1.46M -547.07K -1.49M -1.11M -50.76K -158.01K -266.45K
Capital Expenditures
-127.63K -67.71K -507.15K -271.54K -97.07K -301.91K -13.18K -38.91K n/a n/a n/a n/a n/a n/a 802.00 n/a n/a -802
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-127.63K -67.71K -507.15K -271.54K -97.07K -301.91K -13.18K -38.91K n/a n/a n/a -2.91M n/a n/a 802.00 n/a n/a -802
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 100K 100K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -44K n/a -55.96K n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a 15.95M n/a n/a 2.49K 2.62K -58.8K -190.82K 15K 468.28K 2.91M -50K n/a 18.72M -18.35K -17.67K -35K
Financial Cash Flow
1.11M n/a n/a n/a n/a 15.95M 586.69K 10.07M 4.69M 118.92K 424.28K 2.91M -105.96K 2.91M 18.72M -18.35K 82.33K 65K
Net Cash Flow
-4.28M -1.76M -2.01M -4.28M -5.34M 11.81M -2.07M 6.93M 1.19M -1.97M -3.48M -1.49M -658.33K 1.42M 17.61M -72.61K -70.19K -210.29K
Free Cash Flow
-5.44M -1.75M -1.98M -4.31M -5.35M -4.13M -2.69M -3.13M -3.52M -2.09M -3.9M -1.46M -547.07K -1.49M -1.11M -50.76K -158.01K -267.25K